# Two Bear Capital

> Two Bear Capital invests in founders with breakthrough ideas to solve urgent, complex problems by harnessing life sciences and technology. Founded in 2019 by Mike Goguen, with offices in Menlo Park, San Diego, Boston, and New York, and a home base in Whitefish, Montana.

## Pages
- [Home](https://www.twobearcapital.com/): Overview of Two Bear Capital and the firm's focus areas.
- [Story](https://www.twobearcapital.com/story/): How and why Two Bear Capital was founded.
- [Focus](https://www.twobearcapital.com/focus/): Investment thesis across enterprise technology, cybersecurity, health technology, and life sciences.
- [Portfolio](https://www.twobearcapital.com/portfolio/): Companies in the Two Bear Capital portfolio.
- [Team](https://www.twobearcapital.com/team/): Investors, company building team, operations and services staff, and advisors.
- [Work With Us](https://www.twobearcapital.com/jobs/): Open roles across Two Bear Capital portfolio companies.
- [Pitch Us](https://www.twobearcapital.com/pitch-us/): Pitch your company to Two Bear Capital — share a deck and tell us about your team, market, and traction.
- [Contact](https://www.twobearcapital.com/contact/): How to reach Two Bear Capital for general, partnership, job, or press inquiries.

## Portfolio Companies
- [Abilita Therapeutics](https://www.twobearcapital.com/portfolio/abilita-therapeutics/): Abilita Therapeutics enables discovery of novel therapeutics for previously undruggable membrane protein targets.
- [Arch Systems](https://www.twobearcapital.com/portfolio/arch-systems/): Arch empowers manufacturers with expert, prebuilt data tools to solve problems faster and improve operations at every level of the organization.
- [Binarly](https://www.twobearcapital.com/portfolio/binarly/): Binarly detects and helps remediate known and unknown vulnerabilities at every step of the device and software supply chain.
- [CIQ](https://www.twobearcapital.com/portfolio/ciq/): Do the impossible with CIQ’s secure, reliable, and open infrastructure solutions.
- [Conceal](https://www.twobearcapital.com/portfolio/conceal/): A pioneer in browser-native Security Service Edge (SSE) and proxy-less Zero Trust Network Access (ZTNA) technology.
- [Dymium](https://www.twobearcapital.com/portfolio/dymium/): A data access management company that enables organizations to bring “data access to where data lives.”
- [Elisity](https://www.twobearcapital.com/portfolio/elisity/): Transform network security with Elisity’s IdentityGraph™, ensuring confident policy enforcement and rapid, seamless deployment.
- [Fyr Bio](https://www.twobearcapital.com/portfolio/fyr-bio/): FYR Bio is transforming healthcare by developing diagnostic solutions that utilize novel insights on disease to innovate the next generation of liquid biopsies.
- [Graphiant](https://www.twobearcapital.com/portfolio/graphiant/): Graphiant is a provider of next-generation network services. Graphiant Network Edge is an “as-a-Service” solution that connects enterprise resources, hybrid cloud, network edge, customers, and partners.
- [Gravwell](https://www.twobearcapital.com/portfolio/gravwell/): Gravwell helps organizations detect anomalies, investigate threats, and ensure AI systems behave as intended.
- [Inimmune](https://www.twobearcapital.com/portfolio/inimmune/): Inimmune is a leading vaccine adjuvant and immunotherapy company utilizing the human immune system to prevent and treat disease.
- [Leapfrog Bio](https://www.twobearcapital.com/portfolio/leapfrog-bio/): Leapfrog Bio — accelerating precision oncology, expanding treatment and improving outcomes.
- [Montara Therapeutics](https://www.twobearcapital.com/portfolio/montara-therapeutics/): Montara develops safe and efficacious therapies to improve the lives of patients with neurological diseases.
- [Novoron](https://www.twobearcapital.com/portfolio/novoron/): Novoron Bioscience is pioneering lipoprotein-receptor drug development to repair degeneration of the central nervous system.
- [PulseData](https://www.twobearcapital.com/portfolio/pulsedata/): PulseData provides data driven, clinically validated, predictive insights delivered right at the point of care.
- [QuSecure](https://www.twobearcapital.com/portfolio/qusecure/): QuSecure’s QuProtect addresses today’s and future quantum, AI, and classical threats to encryption.
- [Rainfall Health](https://www.twobearcapital.com/portfolio/rainfall-health/): Rainfall Health helps hospitals quantify, capture, and maximize CMS’s mandated TEAM incentives.
- [Revenium](https://www.twobearcapital.com/portfolio/revenium/): Revenium turns AI usage into ROI clarity — cutting costs, boosting margins, and giving leaders real-time visibility across models and agents.
- [Sanavia Oncology](https://www.twobearcapital.com/portfolio/sanavia-oncology/): Sanavia is redefining the possibilities in the fight against cancer by harnessing scientific research and breakthrough technologies.
- [Selector](https://www.twobearcapital.com/portfolio/selector/): Selector is the industry-leading AIOps platform designed to provide instant, real-time actionable insights for managing multi-domain network and application infrastructures.
- [Talus Bio](https://www.twobearcapital.com/portfolio/talus-bio/): Enabling drug discovery for previously undruggable transcription factors.
- [TileDB](https://www.twobearcapital.com/portfolio/tiledb/): TileDB is the ultimate multi-modal database that morphs to capture all complex analytic applications.

## Team
- [Mark Adams, PhD](https://www.twobearcapital.com/team/mark-adams/): Partner — New York
- [Jenna Aronson, PhD](https://www.twobearcapital.com/team/jenna-aronson/): Principal — Boston
- [Amalia Colangelo, PhD](https://www.twobearcapital.com/team/amalia-colangelo/): Principal — Menlo Park
- [Mike Goguen](https://www.twobearcapital.com/team/mike-goguen/): Founder & Managing Partner — Whitefish
- [Cris Neckar](https://www.twobearcapital.com/team/cris-neckar/): Partner — Menlo Park & Whitefish
- [Lavinia Platerink](https://www.twobearcapital.com/team/lavinia-platerink/): Associate — Menlo Park
- [Avery Sonnenberg, PhD](https://www.twobearcapital.com/team/avery-sonnenberg/): Partner — Whitefish
- [J. Seth Strattan, PhD](https://www.twobearcapital.com/team/j-seth-strattan/): General Partner — Menlo Park
- [John Sullivan](https://www.twobearcapital.com/team/john-sullivan/): Venture Partner — Boston
- [Neil White](https://www.twobearcapital.com/team/neil-white/): Partner — Silicon Valley
- [Kristen Getchell, PhD](https://www.twobearcapital.com/team/kristen-getchell/): Partner, Head of Platform — Boston
- [Nikki Johns](https://www.twobearcapital.com/team/nikki-johns/): VP, Talent Acquisition — Whitefish
- [Jeff Miller](https://www.twobearcapital.com/team/jeff-miller/): Operating Partner, Enterprise — New York
- [Zander Mykytiuk](https://www.twobearcapital.com/team/zander-mykytiuk/): Operating Associate — New York
- [Tim Veil](https://www.twobearcapital.com/team/tim-veil/): Chief Information Officer — New York
- [Ashley Archibeque](https://www.twobearcapital.com/team/ashley-archibeque/): Executive Assistant — Whitefish
- [Erika Bolden](https://www.twobearcapital.com/team/erika-bolden/): Operations Manager — San Diego
- [Kevin Day](https://www.twobearcapital.com/team/kevin-day/): Partner, Head of Capital Formation — New York
- [Meagan Hennig](https://www.twobearcapital.com/team/meagan-hennig/): Partner, Head of Operations — San Diego
- [Rachel Tsunemoto Hislop, PhD](https://www.twobearcapital.com/team/rachel-tsunemoto-hislop/): Principal, Director of Research — San Diego
- [Jennifer Howrigan](https://www.twobearcapital.com/team/jennifer-howrigan/): VP, Investor Relations — New York
- [Bria Iuliano](https://www.twobearcapital.com/team/bria-iuliano/): Executive Assistant — New York
- [Linda Jahn](https://www.twobearcapital.com/team/linda-jahn/): Executive Assistant — Menlo Park
- [Liz Marchi](https://www.twobearcapital.com/team/liz-marchi/): Head of Community Engagement — Whitefish
- [James Allison, PhD](https://www.twobearcapital.com/team/james-allison/): Nobel Laureate, Chair of Immunology, MD Anderson Cancer Center, University of Texas
- [Jim Caggiano](https://www.twobearcapital.com/team/jim-caggiano/): Chief Executive Officer, Evolve Biologics
- [John Delaney, PhD](https://www.twobearcapital.com/team/john-delaney/): Senior Biopharmaceutical Advisor
- [Ellen Lubman, MBA](https://www.twobearcapital.com/team/ellen-lubman/): Biopharmaceutical Advisor
- [Bridget Martell MA, MD](https://www.twobearcapital.com/team/bridget-martell-ma-md/): Senior Biopharmaceutical Advisor — New York
- [Joe Pinto](https://www.twobearcapital.com/team/joe-pinto/): Chief Customer Experience Officer, Pure Storage
- [Padmanee “Pam” Sharma, M.D., PhD](https://www.twobearcapital.com/team/padmanee-sharma/): Professor of Genitourinary Medical Oncology and Immunology in the Division of Cancer Medicine, MD Anderson Cancer Center, University of Texas